Patent ID: 7452893

Claim:
A compound having the formula (I): wherein: R 1 is selected from: unsubstituted or substituted with one or more substituents selected from: halogen, —R 2 , —O—R 2 , —CN, —N(R 2 ) 2 , Y is selected from: wherein the CH 2 moiety is bound to Z and the cyclopropyl moiety is bound to R 1 , —R 3 — and —R 3 —O—R 3 —, where C′ and C″ are each independently directly or indirectly bound to an R 1 phenyl ring to form a 5 to 7 member fused ring; Z is absent or is selected from O, C 1-6 alkylene, C 1-6 alkenylene, C(O), S, SO, SO 2 , NR 4 , where R 4 is hydrogen, C 0-6 alkyl or C 0-6 alkenyl, where said alkyl, alkenyl, alkylene or alkenylene is unsubstituted or is substituted with one or more substituents selected from: halogen, —R 5 , —O—R 5 , —CN, —N(R 5 ) 2 ; A and B are each independently C 0-4 alkyl, where a ring is formed comprising A and B, where each member of said ring is independently unsubstituted or substituted with one or more substituents selected from halogen, —R 6 , —O—R 6 , —CN, —N(R 6 ) 2 ; W is absent or is selected from O, C 0-6 alkylene, C 0-6 alkenylene, C(O), S, SO, SO 2 , NR 7 , where said alkyl, alkenyl, alkylene or alkenylene is unsubstituted or is substituted with one or more substituents selected from halogen, —R 8 , —O—R 8 , —CN, —N(R 8 ) 2 ; is unsubstituted or is substituted with one or more substituents selected from halogen, —R 9 , —O—R 9 , —CN, —N(R 9 ) 2 ; R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, C 0-6 alkyl, C 0-6 alkenyl unsubstituted or substituted with one or more halogen; or a pharmaceutically acceptable salt thereof, or an individual diastereomer thereof.